Examples of 'tumorigenicity' in a sentence
Meaning of "tumorigenicity"
The ability of a substance to induce tumors (noun)
Show more definitions
- The condition of being tumorigenic.
- The extent to which a substance is tumorigenic.
How to use "tumorigenicity" in a sentence
Basic
Advanced
tumorigenicity
Toxicology and tumorigenicity studies are performed as follows.
It could be a case of polymorphism unconnected with tumorigenicity.
The ratio is indicative of tumorigenicity of breast cancer.
A tumorigenicity study in rats revealed an increased incidence of testicular tumours.
These effects are known to correlate with tumorigenicity in mice.
Two independent tumorigenicity studies conducted in the hamster gave negative results.
The given phenotype can be tumorigenicity.
Tumorigenicity may be quantified in numerous ways known to one of skill in the art.
In vitro and in vivo tumorigenicity assays.
The protease also cleaves soluble proteins that are responsible for tumorigenicity.
Tumorigenicity is one major biosafety concern regarding stem cell application in therapeutic protocols.
This assay is known to correlate well with in vivo tumorigenicity.
Tumorigenicity can also be evaluated using the luciferase expression cassettes described herein.
A representative result of tumorigenicity study.
Methods of reducing the tumorigenicity of a tumor that comprises cancer stem cells are also provided.
See also
This may have something to do with the weak tumorigenicity of mezerein.
Tumorigenicity increases with increase in time points of adhesion deprival period and later decreases.
No tumorigenic potential of iloprost could be demonstrated in tumorigenicity studies in rats and mice.
Tumorigenicity studies Subcutaneous tumor xenografts were performed as previously described.
Cell adhesion receptors called integrins have been associated with tumorigenicity and metastasis.
Transformation Assay Tumorigenicity has shown to be closely correlated with the property of transformation.
The cell line must be free from extraneous agents and may be tested for tumorigenicity.
Analysis of Tumorigenicity.
Selected proteases provided herein also can cleave soluble proteins that are responsible for tumorigenicity.
However, glioma tumorigenicity is not controlled uniquely by its genetic alterations.
The inventors hereof found MN proteins to be associated with tumorigenicity.
Detection of transformation and tumorigenicity is done by using the adhesion-deprived cells.
Such cells express a mutant form of EGFR typically associated with tumorigenicity.
Overexpression of SREBP-1c is sufficient to cause tumorigenicity and invasión of prostate cancer cells.
The degree of PCDGF overexpression directly correlates with the degree of cellular tumorigenicity.
A method for diagnosing the tumorigenicity of breast cancer in a human patient, comprising,.
The X gene or modified versions thereof may be tested for tumorigenicity in a variety of ways.
Morphologic investigations and tumorigenicity tests ( nude mice model ) were performed by standard procedures.
Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity.
In other instances, the antibody reduces the tumorigenicity of a tumor that comprises cancer stem cells.
Anchorage-independent growth may be used as a measure of tumorigenicity.
These results suggest that secretory gp96-Ig decreased tumorigenicity of tumors possibly by increasing their immunogenicity.
Further, a mammalian cell isolated from the tumor has a tumorigenicity.
Demonstration that E1A reduces tumorigenicity of human tumor cells.
A key regulator of translational control is eIF4E whose activity is a key determinant of tumorigenicity.
This mechanism has been shown to contribute to tumorigenicity in animals ( van Lohuizen and Bems ).
This invention provides for primary detection of transformation of adhesion-deprived cells and tumorigenicity.
Figure 6 shows that M1 expression reduces the tumorigenicity of lung cancer cells.
These may render the receptor activity independently of ligand binding ( EGFRvIII ) leading to enhanced tumorigenicity.
Assays for Tumorigenicity and Metastasis, Malignant potential was determined as described herein above.
Anchorage-independent growth is highly correlated to tumorigenicity in vivo.
Suppressor of tumorigenicity protein 14 degrades extracellular matrix.
The lack of c-Myc could significantly reduce the tumorigenicity risk.
The results of the tumorigenicity testing is shown in Table 2 in Appendix 1.
By injecting such cell lines to nude mice, an increased tumorigenicity was observed.
